QuickView for penicillanic acid sulfones (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Affymetrix]
5. Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]

1. Sulbactam/Durlobactam: First Approval.
2. Alteration of adeS Contributes to Tigecycline Resistance and Collateral Sensitivity to Sulbactam in …
3. Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam.
4. Development and validation of a nomogram for predicting cefoperazone/sulbactam-induced hypoprothromb…
5. An HPLC-MS/MS method for determination of sulbactam in human plasma and its pharmacokinetic applicat…

There were no clinical trials for penicillanic acid sulfones